With only about 56% of its population fully vaccinated against covid-19 and with the booster dose having been […]
Month: January 2022
As we enter the third year of the covid-19 pandemic, the negative effects have cut across all of […]
It is great to see the topic of overactive bladder coming to the forefront of GP consultations1 considering […]
Consensus is growing that the omicron variant of SARS-CoV-2, which has 50 mutations differentiating it from the original […]
How do you solve a problem as entrenched as racism in health research? Two tools you need are […]
Pfizer in Texas showdown: Court hearing this week will decide if it can assist FDA in providing COVID […]
Novo Nordisk’s Wegovy, hamstrung by Catalent FDA write-up, could correct course by mid-2022: analysts fkansteiner Thu, 01/27/2022 – […]
What competition? Vertex touts Trikafta’s competitive edge on back of strong 2021 fkansteiner Thu, 01/27/2022 – 07:09
Lilly, BMS drugs join top TV ad spenders in December as Dupixent stays on top badams Thu, 01/27/2022 […]
Pharmaceutical researchers speak of a hit when they come across a promising substance with a desired effect in […]